Literature DB >> 20192669

Therapeutic management of intracranial dural arteriovenous shunts with leptomeningeal venous drainage: report of 53 consecutive patients with emphasis on transarterial embolization with acrylic glue.

Pierre Guedin1, Stephan Gaillard, Anne Boulin, Stephanie Condette-Auliac, Frederic Bourdain, Stephanie Guieu, Michel Dupuy, Georges Rodesch.   

Abstract

OBJECT: There is a strong correlation between the venous drainage pattern of intracranial dural arteriovenous shunts (ICDAVSs) and the affected patients' clinical presentation. The ICDAVSs that have cortical venous reflux (CVR) (retrograde leptomeningeal drainage: Borden Type 2 and 3 lesions) are very aggressive and have a poor natural history. Although the necessity of treatment remains debatable in ICDAVSs that drain exclusively into a sinus (Borden Type 1), lesions with CVR must be treated because of the negative effects of the retrograde venous drainage. Surgery, radiosurgery, and embolization have been proposed for management of these lesions, but endovascular therapy is considered the most appropriate therapeutic strategy in ICDAVSs. New embolic materials, such as Onyx, have been recently developed and are considered to represent a kind of "gold standard" for embolization of these lesions. The purpose of this study is to emphasize the importance of transarterial embolization using acrylic glue in the therapeutic management of ICDAVSs with CVR, and to compare the results the authors obtained using this treatment with those reported in the literature for Onyx treatment of the same type of dural shunts.
METHODS: The clinical and radiological records of 53 consecutive patients suffering from ICDAVSs with CVR (Borden Types 2 or 3) were reviewed. All cases were managed with the same angiographic and therapeutic protocol. Localization of the lesions, their clinical symptoms, their angioarchitecture, their therapeutic management, and the results were analyzed.
RESULTS: Fourteen ICDAVSs were located at the superior sagittal sinus and/or convexity veins, 13 at the transverse and sigmoid sinuses, 10 at the tentorium, 5 in the anterior cranial fossa, 4 at the foramen magnum, 3 at the torcula, 2 at the straight sinus, and 1 at the vein of Galen. One patient presented with an infantile form of ICDAVS with multiple shunts. Hemorrhage had occurred in 36% of cases. Forty-three patients underwent transarterial embolization (42 with acrylic glue). Complete closure of the fistula was obtained in 34 patients. Suppression of the CVR with partial occlusion of the main shunt was achieved in all other cases. No mortality or permanent morbidity was observed in this series.
CONCLUSIONS: Intracranial dural arteriovenous shunts can be safely managed by transarterial embolization, which can be considered in most instances as an effective first-intention treatment. Acrylic glue still allows a cheap, fast, and effective treatment with high rates of cures that compare favorably to those obtained with new embolic materials.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20192669     DOI: 10.3171/2009.7.JNS08490

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  18 in total

Review 1.  Intracranial dural arteriovenous fistulas: classification, imaging findings, and treatment.

Authors:  D Gandhi; J Chen; M Pearl; J Huang; J J Gemmete; S Kathuria
Journal:  AJNR Am J Neuroradiol       Date:  2012-01-12       Impact factor: 3.825

2.  Onyx embolization of dural arteriovenous fistulas of the cavernous sinus through the superior pharyngeal branch of the ascending pharyngeal artery.

Authors:  Guglielmo Pero; Luca Quilici; Mariangela Piano; Luca Valvassori; Edoardo Boccardi
Journal:  BMJ Case Rep       Date:  2014-04-23

3.  Endovascular treatment of tentorial dural arteriovenous fistulae.

Authors:  E Wajnberg; G Spilberg; M T Rezende; D G Abud; I Kessler; C Mounayer
Journal:  Interv Neuroradiol       Date:  2012-03-16       Impact factor: 1.610

4.  Safety of Onyx Transarterial Embolization of Skull Base Dural Arteriovenous Fistulas from Meningeal Branches of the External Carotids also Fed by Meningeal Branches of Internal Carotid or Vertebral Arteries.

Authors:  Thiago G Abud; Emmanuel Houdart; Jean-Pierre Saint-Maurice; Daniel G Abud; Carlos E Baccin; Andrew D Nguyen; Nitamar Abdala
Journal:  Clin Neuroradiol       Date:  2017-08-11       Impact factor: 3.649

5.  Transarterial venous sinus occlusion of dural arteriovenous fistulas using ONYX.

Authors:  Collin M Torok; Raul G Nogueira; Albert J Yoo; Thabele M Leslie-Mazwi; Joshua A Hirsch; Christopher J Stapleton; Aman B Patel; James D Rabinov
Journal:  Interv Neuroradiol       Date:  2016-08-16       Impact factor: 1.610

Review 6.  Vascular anomalies of the head and neck: diagnosis and treatment.

Authors:  Frederic Bertino; Anna V Trofimova; Shenise N Gilyard; C Matthew Hawkins
Journal:  Pediatr Radiol       Date:  2021-04-16

7.  The usefulness of subcutaneous infiltration of epinephrine-containing lidocaine for curative transarterial embolization of dural arteriovenous fistula. A technical note.

Authors:  Shigeru Yamauchi; Akimasa Nishio; Yoshinobu Takahashi; Yutaka Mitsuhashi; Yuzo Terakawa; Taichiro Kawakami; Kenji Ohata
Journal:  Interv Neuroradiol       Date:  2014-02-10       Impact factor: 1.610

8.  Onyx versus nBCA and coils in the treatment of intracranial dural arteriovenous fistulas.

Authors:  Douglas M Choo; Jai Jai Shiva Shankar
Journal:  Interv Neuroradiol       Date:  2016-01-08       Impact factor: 1.610

9.  Endovascular treatment of 170 consecutive cranial dural arteriovenous fistulae: results and complications.

Authors:  Gerasimos Baltsavias; Anton Valavanis
Journal:  Neurosurg Rev       Date:  2013-10-08       Impact factor: 3.042

10.  Long-Term Endovascular Treatment Outcome of 46 Patients with Cavernous Sinus Dural Arteriovenous Fistulas Presenting with Ophthalmic Symptoms. A Non-Controlled Trial with Clinical and Angiographic Follow-up.

Authors:  Ali Pashapour; Reza Mohammadian; Firooz Salehpour; Ehsan Sharifipour; Reza Mansourizade; Ali Mahdavifard; Mohamadgharib Salehi; Farhad Mirzaii; Payam Sariaslani; Ghasem Fatahzade Ardalani; Davar Altafi
Journal:  Neuroradiol J       Date:  2014-08-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.